Published in Brain Behav Immun on November 27, 2012
Astrocytes produce IL-19 in response to bacterial challenge and are sensitive to the immunosuppressive effects of this IL-10 family member. Glia (2014) 0.84
Fasting Induces IL-1 Resistance and Free-Fatty Acid-Mediated Up-Regulation of IL-1R2 and IL-1RA. Front Immunol (2014) 0.80
Central Interleukin-1β Suppresses the Nocturnal Secretion of Melatonin. Mediators Inflamm (2016) 0.77
A model to explain specific cellular communications and cellular harmony:- a hypothesis of coupled cells and interactive coupling molecules. Theor Biol Med Model (2014) 0.76
A20 regulates IL-1-induced tolerant production of CXC chemokines in human mesangial cells via inhibition of MAPK signaling. Sci Rep (2015) 0.75
Plasma Levels of the Interleukin-1-Receptor Antagonist Are Lower in Women with Gestational Diabetes Mellitus and Are Particularly Associated with Postpartum Development of Type 2 Diabetes. PLoS One (2016) 0.75
Genes Involved in Interleukin-1 Receptor Type II Activities Are Associated With Asthmatic Phenotypes. Allergy Asthma Immunol Res (2016) 0.75
Early Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human Primates. PLoS Negl Trop Dis (2016) 0.75
Transcriptomic profiles of aging in naïve and memory CD4(+) cells from mice. Immun Ageing (2017) 0.75
Characterisation of the Whole Blood mRNA Transcriptome in Holstein-Friesian and Jersey Calves in Response to Gradual Weaning. PLoS One (2016) 0.75
Association of genetic polymorphisms in IL-1R1 and IL-1R2 genes with IgA nephropathy in the Han Chinese population. Oncotarget (2017) 0.75
Unravelling the pathogenesis of inflammatory bowel disease. Nature (2007) 18.52
Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol (2009) 14.33
Type 2 diabetes as an inflammatory disease. Nat Rev Immunol (2011) 8.30
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98
Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice. Cell (1996) 7.45
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov (2012) 4.40
Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature (2000) 4.36
The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE (2003) 4.14
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. Science (1993) 3.62
cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science (1988) 3.56
Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat Med (2002) 3.36
Detection and characterization of high affinity plasma membrane receptors for human interleukin 1. J Exp Med (1985) 3.00
IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol (2010) 2.99
Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci (2001) 2.93
A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J (1991) 2.85
Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol (2009) 2.80
Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci U S A (1993) 2.67
Interleukin-1 (IL-1) pathway. Sci Signal (2010) 2.58
Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex. J Biol Chem (1995) 2.58
The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol (2005) 2.39
Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends Immunol (2001) 1.95
Shedding of the type II IL-1 decoy receptor requires a multifunctional aminopeptidase, aminopeptidase regulator of TNF receptor type 1 shedding. J Immunol (2003) 1.92
The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci Biobehav Rev (2001) 1.74
Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways. J Biol Chem (2000) 1.65
Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev (2003) 1.62
The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity (2003) 1.61
Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol (1994) 1.61
Leptin modulates beta cell expression of IL-1 receptor antagonist and release of IL-1beta in human islets. Proc Natl Acad Sci U S A (2004) 1.60
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proc Natl Acad Sci U S A (1992) 1.49
A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur J Immunol (1997) 1.43
Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice. Circulation (1998) 1.40
Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Res (1992) 1.37
Blocking interleukin-1β in acute and chronic autoinflammatory diseases. J Intern Med (2011) 1.35
Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am J Physiol Regul Integr Comp Physiol (2000) 1.33
Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci U S A (1995) 1.32
IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes. J Immunol (2005) 1.31
The type II IL-1 receptor interacts with the IL-1 receptor accessory protein: a novel mechanism of regulation of IL-1 responsiveness. J Immunol (1998) 1.24
IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J Immunol (2000) 1.19
Interleukin-1 receptor cluster: gene organization of IL1R2, IL1R1, IL1RL2 (IL-1Rrp2), IL1RL1 (T1/ST2), and IL18R1 (IL-1Rrp) on human chromosome 2q. Genomics (1999) 1.19
Interleukin-1 and interleukin-1 antagonism in sepsis, systemic inflammatory response syndrome, and septic shock. Shock (1995) 1.18
In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccharide (endotoxin) is mediated through interleukin-1. Endocrinology (1989) 1.16
Coupled pre-mRNA and mRNA dynamics unveil operational strategies underlying transcriptional responses to stimuli. Mol Syst Biol (2011) 1.13
Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J Immunol (1994) 1.10
Rilonacept--CAPS and beyond. Ann N Y Acad Sci (2009) 1.09
Acute hypoxia activates the neuroimmune system, which diabetes exacerbates. J Neurosci (2007) 1.07
Role of metalloproteases in the release of the IL-1 type II decoy receptor. J Biol Chem (1997) 1.02
New considerations for the pathogenesis of endometriosis. Int J Gynaecol Obstet (2002) 1.02
Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED. PLoS One (2009) 1.02
Fasting induces an anti-inflammatory effect on the neuroimmune system which a high-fat diet prevents. Obesity (Silver Spring) (2011) 1.01
Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes. J Immunol (1996) 1.00
Suppression of TNF-α and IL-1 signaling identifies a mechanism of homeostatic regulation of macrophages by IL-27. J Immunol (2010) 1.00
Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation. Proc Natl Acad Sci U S A (1997) 0.99
Pathophysiology and treatment of bacterial meningitis. Ther Adv Neurol Disord (2009) 0.98
Inducible expression of type 2 IL-1 receptors by cultured human keratinocytes. Implications for IL-1-mediated processes in epidermis. J Immunol (1995) 0.97
Adipokines from local fat cells shape the macrophage compartment of the creeping fat in Crohn's disease. Gut (2012) 0.96
Chromosomal location of murine and human IL-1 receptor genes. Genomics (1991) 0.96
The type II decoy receptor of IL-1 inhibits murine collagen-induced arthritis. Eur J Immunol (2000) 0.96
Soluble interleukin-1 receptor type II levels are elevated in cerebrospinal fluid in Alzheimer's disease patients. Brain Res (1999) 0.94
Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J Exp Med (1995) 0.94
Interleukin-13 induces expression and release of interleukin-1 decoy receptor in human polymorphonuclear cells. J Biol Chem (1994) 0.93
Systems biology-defined NF-kappaB regulons, interacting signal pathways and networks are implicated in the malignant phenotype of head and neck cancer cell lines differing in p53 status. Genome Biol (2008) 0.93
TNF-alpha, unlike other pro- and anti-inflammatory cytokines, induces rapid release of the IL-1 type II decoy receptor in human myelomonocytic cells. J Immunol (1997) 0.92
Elevated levels of soluble interleukin-1 receptor type II and interleukin-1 receptor antagonist in patients with chronic arthritis: correlations with markers of inflammation and joint destruction. Arthritis Rheum (1998) 0.91
Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations. Rheumatol Int (2011) 0.91
Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol (1992) 0.90
Interleukin-1 receptor accessory protein interacts with the type II interleukin-1 receptor. FEBS Lett (1998) 0.90
Genomic organization of the type I and type II IL-1 receptors. Cytokine (1995) 0.87
IL-1 modulation of cytokine receptors on bone marrow cells. In vitro and in vivo studies. J Immunol (1991) 0.87
Effects of soluble interleukin-1 type II receptor on rabbit antigen-induced arthritis: clinical, biochemical and histological assessment. Rheumatology (Oxford) (1999) 0.86
Molecular characterization of the interleukin-1 receptor (IL-1R) on monocytes and polymorphonuclear cells. Cytokine (1992) 0.85
Concentrations of interleukin (IL)-1alpha, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol (2005) 0.85
Stimulatory effect of interleukin-1 beta on the hypothalamic-pituitary-adrenal axis of the rat: influence of age, gender and circulating sex steroids. J Endocrinol (1994) 0.84
Ectopic expression of interleukin-1 receptor type II enhances cell migration through activation of the pre-interleukin 1alpha pathway. Cytokine (2008) 0.84
Expression of interleukin-1beta, interleukin-1 receptor, and interleukin-1 receptor antagonist mRNA in rat carotid artery after balloon angioplasty. Biochem Biophys Res Commun (2000) 0.83
Gene transfer of a soluble IL-1 type 2 receptor-Ig fusion protein improves cardiac allograft survival in rats. Eur J Cardiothorac Surg (2006) 0.83
Increased serum concentrations of interleukin-1 beta in patients with coronary artery disease. Heart (1996) 0.83
Assessment of human stress and depression by DNA microarray analysis. J Med Invest (2005) 0.83
Expression of interleukin (IL)-1β and IL-1 receptors genes in the hypothalamus of anoestrous ewes after lipopolysaccharide treatment. Reprod Domest Anim (2010) 0.82
Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions. Biochim Biophys Acta (2011) 0.82
The association between endometriosis and polymorphisms in the interleukin-1 family genes in Korean women. Am J Reprod Immunol (2012) 0.81
Interleukin-1 beta and tumour necrosis factor-alpha stimulate the mRNA expression of interleukin-1 receptors in mouse anterior pituitary AtT-20 cells. Neurosci Lett (1995) 0.81
Interleukin-1 receptors type I and type II in the mouse brain: kinetics of mRNA expressions after peripheral administration of bacterial lipopolysaccharide. J Neuroimmunol (1996) 0.81
Imbalance in the expression of the activating type I and the inhibitory type II interleukin 1 receptors in endometriosis. Hum Reprod (2007) 0.81
Decreased expression of the decoy interleukin-1 receptor type II in human endometriosis. Am J Pathol (2001) 0.80
Soluble interleukin-1 receptor type II blocks monocyte chemotactic protein-1 secretion by U937 cells in response to peripheral blood serum of women with endometriosis. Fertil Steril (2002) 0.80
Soluble human IL-1 receptor type 2 inhibits ectopic endometrial tissue implantation and growth: identification of a novel potential target for endometriosis treatment. Am J Pathol (2012) 0.79
The interleukin-1 type 2 receptor gene displays immediate early gene responsiveness in glucocorticoid-stimulated human epidermal keratinocytes. J Biol Chem (1999) 0.78
Blockade of brain type II interleukin-1 receptors potentiates IL1beta-induced anorexia in mice. Neurosci Lett (1998) 0.78
Molecular characterization of the bovine type II IL-1 receptor. Cytokine (1997) 0.78
Aspirin-induced increases in soluble IL-1 receptor type II concentrations in vitro and in vivo. J Leukoc Biol (1999) 0.77
A chimeric type II/type I interleukin-1 receptor can mediate interleukin-1 induction of gene expression in T cells. J Biol Chem (1993) 0.77
Reactive oxygen intermediates cause rapid release of the interleukin-1 decoy receptor from human myelomonocytic cells. Blood (1996) 0.77
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun (2007) 3.07
Behavioral recovery from acute hypoxia is reliant on leptin. Brain Behav Immun (2008) 1.48
Collection of the BD SurePath Pap Test with a broom device plus endocervical brush improves disease detection when compared to the broom device alone or the spatula plus endocervical brush combination. Cytojournal (2008) 1.42
IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes. J Immunol (2005) 1.31
The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer. Metabolism (2012) 1.31
Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide. Endocrinology (2004) 1.14
Acute hypoxia activates the neuroimmune system, which diabetes exacerbates. J Neurosci (2007) 1.07
Fasting induces an anti-inflammatory effect on the neuroimmune system which a high-fat diet prevents. Obesity (Silver Spring) (2011) 1.01
Novel activity of an anti-inflammatory cytokine: IL-10 prevents TNFalpha-induced resistance to IGF-I in myoblasts. J Neuroimmunol (2007) 1.01
Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is dependent on elevated glucose and requires p38 MAPK. J Immunol (2007) 1.01
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays. J Clin Microbiol (2007) 1.00
Insulin receptor substrate-2-dependent interleukin-4 signaling in macrophages is impaired in two models of type 2 diabetes mellitus. J Biol Chem (2004) 0.98
Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor. Cancer Res (2002) 0.98
Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through up-regulation of IL-4 and Th2 polarization. Brain Behav Immun (2010) 0.97
The implication of proinflammatory cytokines in type 2 diabetes. Front Biosci (2008) 0.97
C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts. Endocrinology (2006) 0.96
A reduced carbohydrate, increased protein diet stabilizes glycemic control and minimizes adipose tissue glucose disposal in rats. J Nutr (2006) 0.95
Mouse testing methods in psychoneuroimmunology: an overview of how to measure sickness, depressive/anxietal, cognitive, and physical activity behaviors. Methods Mol Biol (2012) 0.95
The biobehavioral and neuroimmune impact of low-dose ionizing radiation. Brain Behav Immun (2011) 0.95
Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice. Psychoneuroendocrinology (2013) 0.94
Methylglyoxal enhances cisplatin-induced cytotoxicity by activating protein kinase Cdelta. J Biol Chem (2001) 0.94
Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness. Proc Natl Acad Sci U S A (2005) 0.92
Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1. J Neurosci (2012) 0.91
Effect of live-fire training drills on firefighters' platelet number and function. Prehosp Emerg Care (2011) 0.91
Phagocytosis of cholesteryl ester is amplified in diabetic mouse macrophages and is largely mediated by CD36 and SR-A. PLoS One (2007) 0.91
Macropinocytosis is decreased in diabetic mouse macrophages and is regulated by AMPK. BMC Immunol (2008) 0.91
IL-10 promotes survival of microglia without activating Akt. J Neuroimmunol (2002) 0.89
Individually ventilated cages cause chronic low-grade hypoxia impacting mice hematologically and behaviorally. Brain Behav Immun (2012) 0.87
Leucine reduces the duration of insulin-induced PI 3-kinase activity in rat skeletal muscle. Am J Physiol Endocrinol Metab (2004) 0.87
Gender plays no role in student ability to perform on computer-based examinations. BMC Med Educ (2006) 0.87
Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts. Endocrinology (2003) 0.86
Macrophages make me sick: how macrophage activation states influence sickness behavior. Psychoneuroendocrinology (2011) 0.86
Vanadate and rapamycin synergistically enhance insulin-stimulated glucose uptake. Metabolism (2003) 0.86
Dual sampling of the endocervix and its impact on AutoCyte Prep endocervical adequacy. Am J Clin Pathol (2002) 0.86
Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice. Brain Behav Immun (2013) 0.85
Accelerated recovery from acute hypoxia in obese mice is due to obesity-associated up-regulation of interleukin-1 receptor antagonist. Endocrinology (2009) 0.85
Acute hypoglycemia causes depressive-like behaviors in mice. Metabolism (2011) 0.85
Acute hypoxia, diabetes, and neuroimmune dysregulation: converging mechanisms in the brain. Neuroscientist (2007) 0.84
IL-4-dependent CD86 expression requires JAK/STAT6 activation and is negatively regulated by PKCdelta. Cell Signal (2004) 0.84
Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis. J Biol Chem (2003) 0.83
IL-1beta suppresses prolonged Akt activation and expression of E2F-1 and cyclin A in breast cancer cells. J Immunol (2004) 0.82
Additional collection devices used in conjunction with the SurePath Liquid-Based Pap Test broom device do not enhance diagnostic utility. BMC Womens Health (2004) 0.82
IL-4 Knock Out Mice Display Anxiety-Like Behavior. Behav Genet (2015) 0.80
Mouse short- and long-term locomotor activity analyzed by video tracking software. J Vis Exp (2013) 0.80
Test performance comparison of inform HPV and hybrid capture 2 high-risk HPV DNA tests using the SurePath liquid-based Pap test as the collection method. Am J Clin Pathol (2005) 0.79
Ca2+/calmodulin-dependent kinase kinase alpha is expressed by monocytic cells and regulates the activation profile. PLoS One (2008) 0.79
Blocking of beta-2 adrenergic receptors hastens recovery from hypoglycemia-associated social withdrawal. Psychoneuroendocrinology (2008) 0.78
Psychoneuroimmune implications of type 2 diabetes. Neurol Clin (2006) 0.78
LPS-dependent suppression of social exploration is augmented in type 1 diabetic mice. Brain Behav Immun (2007) 0.78
New red blood cell lysing fixative for use in fine needle aspiration and fluid cytology. Acta Cytol (2003) 0.76
Cytokines in type 2 diabetes. Vitam Horm (2006) 0.76
Psychoneuroimmune implications of type 2 diabetes: redux. Immunol Allergy Clin North Am (2009) 0.76
Market survey predictions on the future of US Pap testing. Cytojournal (2009) 0.75
Medical students who decompress during the M-1 year outperform those who fail and repeat it: a study of M-1 students at the University of Illinois College of Medicine at Urbana-Champaign 1988-2000. BMC Med Educ (2005) 0.75
Development of a Lactobacillus specific T-RFLP method to determine lactobacilli diversity in complex samples. J Microbiol Methods (2012) 0.75
Effectiveness of the SurePath liquid-based Pap test in automated screening and in detection of HSIL. Diagn Cytopathol (2003) 0.75